This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (87)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

T. VAN Joost, MD; E. Stolz, MD; F. Heule, MD
Faculty of Medicine Erasmus University Rotterdam, the Netherlands

Arch Dermatol. 1987;123(2):166-167.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Cyclosporine is a drug that is new to dermatology and, therefore, awaits further study.^1,2 Its use, however, must be closely monitored because of possible side effects.¹ Recently, in psoriasis the favorable effect of low-dose cyclosporine (5 mg/ kg/d) treatment in patients with severe drug-resistant psoriasis has been reported.^3,4 Studies on cyclosporine therapy in severe cases of drug-resistant atopic dermatitis have not yet been reported, to our knowledge.

Report of a Case.—

We have observed the temporary effect of short-term cyclosporine treatment in two women (Table), with severe, drug-resistant, pruritic, activedisseminated, chronic prurigolike lesions and eczema. Case 1 was classified as atopic dermatitis with serum IgE levels greater than or equal to 20000 IU/mL (48000 µg/L).

Clinical Data on Cyclosporine Treatment in Two Patients With Severe Drug Resistant Atopic Dermatitis Body Area Affected, % Improve-Patient ment Cyclosporine No./ After 4 After 4 Blood Age, y/ Start . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?